ÂÜÀòÂÒÂ×

Bihua Feng is a highly experienced scientist with a strong background in biomedical research, possessing expertise in bioanalytical assays, next-generation sequencing, and molecular biology techniques. Currently serving as a Scientist at Biomere, Bihua Feng leads assay development and data reporting across multiple platforms, contributing to advancements in pharmacokinetic and pharmacodynamic studies. Prior roles include significant positions at Boston University School of Medicine, where Bihua Feng conducted extensive RNA sequencing and data analysis, and at Brigham and Women's Hospital, focusing on innovative technologies such as single-cell analysis and CRISPR methodologies. With a PhD in Medicine from Shanghai Jiao Tong University and extensive research experience in both clinical and laboratory settings, Bihua Feng has made notable contributions to the understanding of endothelial dysfunction and cellular mechanisms in various medical contexts.